Sierra Ocean’s Beam Therapeutics BEAM Stock Holding History

Sierra Ocean’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-119	Closed	-$2.02K	–	150
2025 Q2	$2.02K	Buy	+119	New	+$2.07K	﹤0.01%	761

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Sierra Ocean's BEAM Position: Q3 2025 in Review

Sierra Ocean sold out of Beam Therapeutics (BEAM) in Q3 2025, closing a stake of 119 shares — an estimated $2.02K sold.

Sierra Ocean first reported a position in BEAM in Q2 2025 and held it in 1 quarter. The position peaked at $2.02K in Q2 2025. 218 funds tracked by Wall St. Rank hold BEAM as of Q3 2025.

Sierra Ocean reported no remaining Beam Therapeutics position as of Q3 2025 after selling out during the quarter.
Sierra Ocean sold 119 Beam Therapeutics shares in Q3 2025, an estimated $2.02K.
Sierra Ocean first reported a position in Beam Therapeutics in Q2 2025 and held it in 1 quarter.
Sierra Ocean's Beam Therapeutics position peaked at $2.02K in Q2 2025.
218 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2025.

Based on Sierra Ocean's 13F filing for Q3 2025, filed 7 Nov 2025.